Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Raya to Buy 30% of 10th Ramadan Drug Manufacturing

Jan. 3 (Bloomberg) -- Raya Holding Co., an Egyptian information technology firm, said its board approved buying a 30 percent stake in 10th of Ramadan Drug Manufacturing valued at as much as 214.8 million Egyptian pounds ($37 million).

The company will buy 120,000 shares at a maximum price of 1,789.93 Egyptian pounds per share of the drugmaker, Chairman and Chief Executive Officer Medhat Khalil said in a telephone interview today.

“We think this factory has huge potential, especially after we are able to modernize it,” Khalil said.

Raya shares gained as much as 1.8 percent to 6.1 pounds before trading 0.2 percent higher at 11:48 a.m. in Cairo. That valued Raya at 373 million pounds.

To contact the reporter on this story: Ahmed A Namatalla in Cairo at anamatalla@bloomberg.net

To contact the editor responsible for this story: Mahmoud Kassem at mkassem1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.